Morgan Stanley Maintains Underweight on Virtus Inv, Lowers Price Target to $112
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $128 to $112.
Morgan Stanley analyst Michael Cyprys maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $128 to $112.